» Articles » PMID: 39045152

Editorial: Translational Control in Cancer

Overview
Journal NAR Cancer
Specialty Oncology
Date 2024 Jul 24
PMID 39045152
Authors
Affiliations
Soon will be listed here.
References
1.
Cammas A, Desprairies A, Dassi E, Millevoi S . The shaping of mRNA translation plasticity by RNA G-quadruplexes in cancer progression and therapy resistance. NAR Cancer. 2024; 6(2):zcae025. PMC: 11140630. DOI: 10.1093/narcan/zcae025. View

2.
Anazco-Guenkova A, Miguel-Lopez B, Monteagudo-Garcia O, Garcia-Vilchez R, Blanco S . The impact of tRNA modifications on translation in cancer: identifying novel therapeutic avenues. NAR Cancer. 2024; 6(1):zcae012. PMC: 10928989. DOI: 10.1093/narcan/zcae012. View

3.
Hwang S, Denicourt C . The impact of ribosome biogenesis in cancer: from proliferation to metastasis. NAR Cancer. 2024; 6(2):zcae017. PMC: 11023387. DOI: 10.1093/narcan/zcae017. View

4.
Dasgupta A, Prensner J . Upstream open reading frames: new players in the landscape of cancer gene regulation. NAR Cancer. 2024; 6(2):zcae023. PMC: 11106035. DOI: 10.1093/narcan/zcae023. View

5.
Roman A, Benitez D, Diaz-Pizarro A, Del Valle-Del Pino N, Olivera-Gomez M, Cumplido-Laso G . Next generation sequencing technologies to address aberrant mRNA translation in cancer. NAR Cancer. 2024; 6(2):zcae024. PMC: 11094761. DOI: 10.1093/narcan/zcae024. View